Sector
PharmaceuticalsOpen
₹114.7Prev. Close
₹112.62Turnover(Lac.)
₹86.7Day's High
₹114.7Day's Low
₹109.8752 Week's High
₹128.952 Week's Low
₹79.49Book Value
₹49.9Face Value
₹10Mkt Cap (₹ Cr.)
541.68P/E
46.12EPS
2.41Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 50.08 | 48.73 | 48.73 | 16.24 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 194.43 | 183.23 | 145.45 | 153.86 |
Net Worth | 244.51 | 231.96 | 194.18 | 170.1 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 303.62 | 274.31 | 271.89 | 235.01 |
yoy growth (%) | 10.68 | 0.89 | 15.69 | -12.4 |
Raw materials | -158.63 | -143.13 | -140.88 | -119.96 |
As % of sales | 52.24 | 52.17 | 51.81 | 51.04 |
Employee costs | -34.48 | -50.61 | -40.8 | -32.99 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 13.76 | -1.48 | 18.25 | 17.57 |
Depreciation | -14.61 | -13.27 | -9.78 | -9.02 |
Tax paid | -2.96 | 3.22 | -5.82 | 1.08 |
Working capital | 6.4 | 3.92 | -1.98 | 0.76 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 10.68 | 0.89 | 15.69 | -12.4 |
Op profit growth | 86.08 | -41.75 | 7.58 | 7.94 |
EBIT growth | 120.7 | -59.53 | 0.71 | 12.31 |
Net profit growth | 222.65 | -90.48 | -2.02 | 262.77 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 379.03 | 367.42 | 398.53 | 333.43 | 307.26 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 379.03 | 367.42 | 398.53 | 333.43 | 307.26 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 5.78 | 5.18 | 6.41 | 4.4 | 2.34 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Anwar S Daud
Director (Finance)
Zulfiquar M Kamal
Whole Time Director
Prakash Sapkal
Director (Business Developmnt)
Niraj Dhadiwal
Independent Director
Kavita Loya
Independent Director
Padmakar Joshi
Company Sec. & Compli. Officer
Piyush Nikhadi
Independent Director
Kamlesh Shende
Independent Director
Ashok Bhatia
Sadoday Gyan (Gr Floor),
Opp NADT Nelson Square,
Maharashtra - 440013
Tel: 91-712-2588070
Website: http://www.zimlab.in
Email: [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fr...
Read More
Reports by Zim Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.